Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Rituximab + Venetoclax for Marginal Zone Lymphoma
Recruiting1 awardPhase 2
New York, New York
This trial will help researchers understand if combining venetoclax with rituximab is effective in treating those with MZL who have not received prior treatment for their cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.